National Framework Agreement for Non-Wire Lesion Localisation and Sentinel Lymph Node Location Products

Description

The Countess of Chester Hospital NHS Foundation Trust, through its commercial procurement services, has awarded a national framework agreement with 4 lots: Lot 1a: supply of non-wire lesion localisation detectors; Lot 1b: supply of non-wire lesion localisation implants and associated implantation devices; Lot 2a: supply of sentinel lymph node location detectors; Lot 2b: supply of sentinel lymph node location tracer fluids, except radioisotopes. Lot 1a: Supply of non-wire lesion localisation detectors Products that enable accurate location of and guidance to non-palpable lesions without use of a localisation guide wire by locating and indicating the position of an implanted lesion localisation implant. Lot 1b: Supply of Non-wire Lesion Localisation Implants and Associated Implantation Devices Products that enable accurate location of and guidance to non-palpable lesions without use of a localisation guide wire. Lot 2a: Supply of Sentinel Lymph Node Location Detectors Products that enable accurate location of sentinel lymph nodes in patients (who have been previously injected with tracer fluid) Lot 2b: Supply of Sentinel Lymph Node Location Tracer Fluids, Except Radioisotopes Non-radioisotope sentinel lymph node location tracer fluid that is suitable for injection into interstitial tissue. Supply of radioisotopes for sentinel lymph node location is outside the scope of this Lot of this framework agreement.